BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35038609)

  • 1. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
    Tipping AD; Nowels M; Moore C; Samples H; Crystal S; Olfson M; Williams AR; Heaps-Woodruff J
    J Subst Use Addict Treat; 2024 Feb; 157():209218. PubMed ID: 37984564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
    Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
    Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
    Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
    Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
    Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
    Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetration.
    Crystal S; Nowels M; Olfson M; Samples H; Williams AR; Treitler P
    J Subst Abuse Treat; 2021 Dec; 131():108546. PubMed ID: 34391586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use.
    Noam KR; Schmutte TJ; Pirard S; Bourdon C; Langless D; Plant R
    J Addict Med; 2023 May-Jun 01; 17(3):e199-e201. PubMed ID: 37267183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose.
    Treitler P; Crystal S; Cantor J; Chakravarty S; Kline A; Morton C; Powell KG; Borys S; Cooperman NA
    JAMA Netw Open; 2024 Mar; 7(3):e243614. PubMed ID: 38526490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
    Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
    J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults.
    Alinsky RH; Zima BT; Rodean J; Matson PA; Larochelle MR; Adger H; Bagley SM; Hadland SE
    JAMA Pediatr; 2020 Mar; 174(3):e195183. PubMed ID: 31905233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
    Johnson K; Hills H; Ma J; Brown CH; McGovern M
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.
    Watson DP; Weathers T; McGuire A; Cohen A; Huynh P; Bowes C; O'Donnell D; Brucker K; Gupta S
    Drug Alcohol Depend; 2021 Apr; 221():108595. PubMed ID: 33610095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.
    Hartung DM; Johnston KA; Hallvik S; Leichtling G; Geddes J; Hildebran C; Keast S; Chan B; Korthuis PT
    J Gen Intern Med; 2020 Nov; 35(11):3188-3196. PubMed ID: 32935311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
    Medicaid Outcomes Distributed Research Network
    J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
    Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
    JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
    Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
    Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.